157 related articles for article (PubMed ID: 9338470)
21. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
22. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
Tao Y; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905
[TBL] [Abstract][Full Text] [Related]
25. Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells.
Firth JD; Putnins EE; Larjava H; Uitto VJ
Infect Immun; 1997 Dec; 65(12):4931-6. PubMed ID: 9393778
[TBL] [Abstract][Full Text] [Related]
26. Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Gokaslan ZL; Chintala SK; York JE; Boyapati V; Jasti S; Sawaya R; Fuller G; Wildrick DM; Nicolson GL; Rao JS
Clin Exp Metastasis; 1998 Nov; 16(8):721-8. PubMed ID: 10211985
[TBL] [Abstract][Full Text] [Related]
27. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T
Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070
[TBL] [Abstract][Full Text] [Related]
28. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of human osteoblastic cells in culture: modulation of proteases by extracellular matrix and tumor necrosis factor-alpha.
Panagakos FS; Kumar S
Inflammation; 1995 Aug; 19(4):423-43. PubMed ID: 7558248
[TBL] [Abstract][Full Text] [Related]
30. Lung alveolar epithelial cells synthesize interstitial collagenase and gelatinases A and B in vitro.
Pardo A; Ridge K; Uhal B; Sznajder JI; Selman M
Int J Biochem Cell Biol; 1997 Jun; 29(6):901-10. PubMed ID: 9304805
[TBL] [Abstract][Full Text] [Related]
31. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y
Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086
[TBL] [Abstract][Full Text] [Related]
32. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
34. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
Tyagi SC; Kumar S; Cassatt S; Parker JL
Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
[TBL] [Abstract][Full Text] [Related]
35. Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.
Furuya M
Hokkaido Igaku Zasshi; 1999 Mar; 74(2):145-55. PubMed ID: 10386163
[TBL] [Abstract][Full Text] [Related]
36. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
37. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
39. Cytokines stimulate matrix metalloproteinase production by human pulp cells during long-term culture.
O'Boskey FJ; Panagakos FS
J Endod; 1998 Jan; 24(1):7-10. PubMed ID: 9487857
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression.
Murthi P; Barker G; Nowell CJ; Rice GE; Baker MS; Kalionis B; Quinn MA
Gynecol Oncol; 2004 Jan; 92(1):80-8. PubMed ID: 14751142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]